..............page:812-813
..............page:794-798
..............page:712-717
..............page:802-804
DEA-and MPI-based analysis of total factor productivity of high level(Level 3) comprehensive military hospitals
HU Xiao-yuan1;SHA Kun2;SUN Qing-wen3;YANG Shao-chun4;YU Gang4;GUO Qiang2 1.Division of Scientific Research Administration;Second Military Medical University;Shanghai 200433;China 2.Division of Training;Second Military Medical University;Shanghai 200433;China 3.Department of Mathematics & Physics;College of Basic Medical Sciences;Second Military Medical University;Shanghai 200433;China 4.Department of Finance;Changhai Hospital;Second Military Medical University;Shanghai 200433;China
..............page:805-807
..............page:697-702
..............page:732-737
Multi-effect of central nitric oxide on cardiovascular activity
ZHANG Ru-wen1;2;SHEN Du1;2;SUN Wei-wei3;WANG Yang-kai1;BAI Jie2;YUAN Wen-jun1;2;WANG Wei-zhong1 1.Department of Physiology;College of Basic Medical Sciences;Second Military Medical University;Shanghai 200433;China 2.Department of Physiology;Basic Medical School;Ningxia Medical University;Yinchuan 750004;Ningxia;China 3.Department of Computer;College of Basic Medical Sciences;Second Military Medical University;Shanghai 200433;China
..............page:718-720
..............page:727-731
Determination of levamlodipine concentration by LC-MS/MS and its chiral transformation potential in human plasma
FANG Jing1;2;FAN Guo-rong2;LI Ji2;LI You2;3;HE Jian-chang4;XU Gui-li4;LI Fa-mei1 1.Department of Analytical Chemistry;School of Pharmacy;Shenyang Pharmaceutical University;Shenyang 110016;Liaoning;China 2.Department of Pharmaceutical Analysis;School of Pharmacy;Second Military Medical University & Key Laboratory of Shanghai Drug Metabolism Research;Shanghai 200433;China 3.Department of Biological Technology;College of Food Science & Technology;Shanghai Ocean University;Shanghai 201306;China 4.Research Section for PhaseⅠClinical Trial;State Base for Drug Clinical Trial;Kunming General Hospital;PLA Chengdu Military Area Command;Kunming 650031;Yunnan;China
..............page:763-769
..............page:707-711
..............page:703-706
..............page:785-788
..............page:808-809
..............page:759-762
..............page:789-793
..............page:742-746
..............page:770-779
Chuan’agelei and its flatten structure ferulic acid and ligustrazine: mass fragmentation pathway
WU Ji-yang1;GAO Fang-yuan1;YE Xiao-lan1;2;LIU Hua1;FAN Guo-rong1;HE Guang-wei3 1.Department of Pharmaceutical Analysis;School of Pharmacy;Second Military Medical University;Shanghai Key Laboratory for Pharmaceutical Metabolite Research;Shanghai 200433;China 2.Department of Pharmaceutical Analysis;Guangdong Pharmaceutical University;Guangzhou 510000;Guangdong;China 3.Hefei Medical Engineering Pharmaceutical Co.Ltd.;Hefei 230088;Anhui;China
..............page:755-758
..............page:810-811
..............page:750-754
..............page:799-802
..............page:747-749
..............page:738-741
Construction of mouse wide-type and mutant dynactin-1 vectors and their expression in mouse podocytes
WANG Chun-hua1;LI Lin2;FU Peng1;LI Jin-hua1;3;YUAN Ai-hong1;SUN Xiang-hua4;JIANG Xiao-feng1;YU Chen1 1.Department of Nephrology;Tongji Hospital;Tongji University;Shanghai 200065;China 2.Department of Nephrology;Changzheng Hospital;Second Military Medical University;Shanghai 200003;China 3.The 6th Division of Nephrology;Jiujiang TCM Hospital;Jiujiang 332000;Jiangxi;China 4.Department of Clinical Laboratory;Tongji Hospital;Tongji University;Shanghai 200065;China
..............page:780-784
..............page:721-726